A)* | ||||
---|---|---|---|---|
RESPONDENTS’ UNDERSTANDING, N (%) | ||||
TECHNICAL TERMS | IT WOULD NOT BE HELPFUL TO ME TO UNDERSTAND | DO NOT UNDERSTAND BUT WOULD LIKE TO | SOME UNDERSTANDING | YES, I UNDERSTAND AND COULD EXPLAIN TO OTHERS |
Relative risk | 29 (20.5) | 27 (19.1) | 49 (34.7) | 36 (25.5) |
Absolute risk | 26 (18.4) | 23 (16.3) | 51 (36.1) | 41 (29.0) |
Systematic review | 28 (19.8) | 24 (17.0) | 48 (34.0) | 41 (29.0) |
Odds ratio | 32 (22.6) | 41 (29.0) | 46 (32.6) | 22 (15.6) |
Meta-analysis | 34 (24.1) | 55 (39.0) | 27 (19.1) | 25 (17.7) |
B)* | ||||
RESPONDENTS’ UNDERSTANDING, N (%) | ||||
TECHNICAL TERMS | IT WOULD NOT BE HELPFUL TO ME TO UNDERSTAND | DO NOT UNDERSTAND BUT WOULD LIKE TO | SOME UNDERSTANDING | YES, I UNDERSTAND AND COULD EXPLAIN TO OTHERS |
Clinical effectiveness | 32 (22.6) | 24 (17.0) | 56 (39.7) | 29 (20.5) |
Number needed to treat | 36 (25.5) | 47 (33.3) | 27 (19.1) | 31 (21.9) |
Confidence interval | 35 (24.8) | 36 (25.5) | 50 (35.4) | 20 (14.1) |
Heterogeneity | 36 (25.5) | 60 (42.5) | 34 (24.1) | 11 (7.8) |
Publication bias | 33 (23.4) | 58 (41.1) | 35 (24.8) | 15 (10.6) |
↵* Table 6 is divided into parts A and B for technical reasons.